Home Economy Incentives for phase 1 clinical trials, cost advantage will help India to tap global opportunity: Parexel India MD Sanjay Vyas
Incentives for phase 1 clinical trials, cost advantage will help India to tap global opportunity: Parexel India MD Sanjay Vyas
Businessline spoke to Sanjay Vyas, President and Managing Director, Parexel India, on the industry scenario and business plans for Parexel
A return to ‘the Portlandia economy’? Not without hospitality jobs, city economists say – OregonLive.com
A return to ‘the Portlandia economy’? Not without hospitality jobs, city economists say O…
